Home > News > Close Brothers Seydler issues 'buy' recommendation for Nanostart and EUR30.8 price target
December 6th, 2010
Close Brothers Seydler issues 'buy' recommendation for Nanostart and EUR30.8 price target
Abstract:
Equity research firm Close Brothers Seydler released a report on nanotechnology investor Nanostart AG on Friday, stating a 'buy' recommendation and a price target of EUR 30.80, nearly double its last closing price.
Frankfurt-based Nanostart invests in emerging nanotechnology companies, both public and private, that span across Europe, Asia and the US. With EUR 35 million invested to date, its current portfolio consists of nine companies across a variety of industries.
"The biggest holding, MagForce, is a shining star of the portfolio, having developed a revolutionary treatment for solid tumor brain cancers. The second largest holding, ItN, is leading the way in water filtration using ceramic treated with nanotechnology," said Close Brothers.
The research firm also noted that Nanostart is partnered with the Singaporean government and works closely in a joint fund to invest in companies out of Asia, giving it a "first-mover advantage".
Source:
proactiveinvestors.com.au
Bookmark:
| Related News Press |
News and information
Quantum computer improves AI predictions April 17th, 2026
Flexible sensor gains sensitivity under pressure April 17th, 2026
A reusable chip for particulate matter sensing April 17th, 2026
Detecting vibrational quantum beating in the predissociation dynamics of SF6 using time-resolved photoelectron spectroscopy April 17th, 2026
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Water
Taking salt out of the water equation October 7th, 2022
Nanobiotechnology
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||